63 studies on P21 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Modern Aminos | 2 | 98.75% | View COA → |
Recent certificates: #57930 (99.17%) · #55913 (98.36%) · #40642 (98.745%)
Manufacturers with published third-party certificates of analysis for P21. Open a vendor to see every batch we've verified.
This research highlights the therapeutic potential of senolytic peptides like FOXO4-DRI in targeting and removing harmful senescent cells from cartilage. By selectively eliminating these dysfunctional cells, FOXO4-DRI…
This research highlights FOXO4-DRI as a potent anti-senolytic agent, capable of rejuvenating endothelial cells and improving vascular health by modulating the P53 pathway. The ability to reverse cellular aging in the …
This research is critical for understanding the molecular mechanisms behind skin aging and its response to environmental stressors like UVB. If Insulin-Like Growth Factor 1 proves effective in modulating gene expressi…
This study is significant because it could establish Adrenomedullin as a crucial biomarker for Acute Myeloid Leukemia prognosis and treatment response. If Adrenomedullin levels accurately reflect disease burden and pr…
This study represents a crucial step towards developing more effective and potentially less toxic treatments for pediatric CNS malignancies. The SGT-53 gene therapy, which targets the p53 tumor suppressor gene (a crit…
This study is crucial for understanding the pleiotropic effects of metformin beyond its well-known glucose-lowering capabilities, specifically its potential role in modulating molecular aging processes in prediabetes.…
P21 is a synthetic peptide, precisely defined by its PubChem CID **56599151**, molecular formula **C27H42N6O8**, and a molecular weight of **578.7 g/mol**.
This research highlights TSPAN9 as a novel and potent regulator of chondrocyte health, offering a promising therapeutic avenue for osteoarthritis. By promoting mitocytosis, TSPAN9 effectively clears damaged mitochondr…
This research highlights the critical role of glial cell senescence as a potential driver of Alzheimer's Disease progression, rather than merely a consequence of aging. Understanding these cell type-specific and age-d…
This study represents a significant breakthrough, demonstrating that rational design can yield potent and selective allosteric activators of PAK1 with therapeutic potential. The robust improvements in cognition, synap…
This research elucidates a critical molecular pathway by which GHRH antagonists like JMR-132 exert their anti-cancer effects, specifically highlighting the essential role of p21/waf1 (a protein that halts cell divisio…
This research highlights the therapeutic potential of GHRH antagonists as a novel and targeted approach for treating prostate cancer. By modulating key cellular pathways, specifically restoring the function of the p53…
This research significantly advances our understanding of the molecular basis of umami taste, particularly through the novel mechanism of peptide mineral chelates. The identification of specific potent umami peptides …
Free, no account — handy when you're working with P21.